Rong-fu Zhou

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Two cases of coagulation factor Ⅺ deficiency caused by compound heterozygous mutations

Two cases of coagulation factor Ⅺ deficiency caused by compound heterozygous mutations

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: July 01, 2022

What can we expect for adolescents and adults with haemophilia switched to low-dose prophylaxis from episodic treatment for over 3 years? A real-world snapshot in China.

What can we expect for adolescents and adults with haemophilia switched to low-dose prophylaxis from episodic treatment for over 3 years? A real-world snapshot in China.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 25, 2021

Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.

Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.

Journal: JAMA network open

Published: October 08, 2020

Age-related severity and distribution of haemophilic arthropathy of the knee, ankle and elbow among Chinese patients with haemophilia.

Age-related severity and distribution of haemophilic arthropathy of the knee, ankle and elbow among Chinese patients with haemophilia.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 30, 2019

Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells through Nuclear Factor-κB Signaling Pathway.

Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells through Nuclear Factor-κB Signaling Pathway.

Journal: Chinese medical journal

Published: February 17, 2018

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Journal: International journal of hematology

Published: November 28, 2017

JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.

JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 24, 2016

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP.

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP.

Journal: Medicine

Published: September 24, 2016

Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.

Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.

Journal: Oncotarget

Published: July 25, 2016

MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

Journal: Histology and histopathology

Published: October 02, 2015

MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy.

MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: January 06, 2014

Meta-analysis of randomised clinical trials comparing idarubicin + cytarabine with daunorubicin + cytarabine as the induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia.

Meta-analysis of randomised clinical trials comparing idarubicin + cytarabine with daunorubicin + cytarabine as the induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia.

Journal: PloS one

Published: November 04, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026